CoChat

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Open access
Bergström, Sofia, Öijerstedt, Linn, Remnestål, Julia, Olofsson, Jennie, Ullgren, Abbe, Seelaar, Harro, van Swieten, John C., Synofzik, Matthis, Sanchez-Valle, Raquel, Moreno, Fermin, Finger, Elizabeth, Masellis, Mario, Tartaglia, Carmela, Vandenberghe, Rik, Laforce, Robert, Galimberti, Daniela, Borroni, Barbara, Butler, Chris R., Gerhard, Alexander, Ducharme, Simon, Rohrer, Jonathan D., Månberg, Anna, Graff, Caroline, Nilsson, Peter, on behalf of the Genetic Frontotemporal Dementia Initiative (GENFI), Jiskoot, Lize, Rowe, James B., de Mendonça, Alexandre, Tagliavini, Fabrizio, Santana, Isabel, Le Ber, Isabelle, Levin, Johannes, Danek, Adrian, Otto, Markus, Frisoni, Giovanni, Ghidoni, Roberta, Sorbi, Sandro, Pasquier, Florence, Jelic, Vesna, Andersson, Christin, Afonso, Sónia, Almeida, Maria Rosario, Anderl-Straub, Sarah, Antonell, Anna, Archetti, Silvana, Arighi, Andrea, Balasa, Mircea, Barandiaran, Myriam, Bargalló, Nuria, Bartha, Robart, Bender, Benjamin, Benussi, Alberto, Benussi, Luisa, Bessi, Valentina, Binetti, Giuliano, Black, Sandra, Bocchetta, Martina, Borrego-Ecija, Sergi, Bras, Jose, Bruffaerts, Rose, Cañada, Marta, Cantoni, Valentina, Caroppo, Paola, Cash, David, Castelo-Branco, Miguel, Convery, Rhian, Cope, Thomas, Di Fede, Giuseppe, Díez, Alina, Duro, Diana, Fenoglio, Chiara, Ferrari, Camilla, Ferreira, Catarina B., Fox, Nick, Freedman, Morris, Fumagalli, Giorgio, Gabilondo, Alazne, Gasparotti, Roberto, Gauthier, Serge, Gazzina, Stefano, Giaccone, Giorgio, Gorostidi, Ana, Greaves, Caroline, Guerreiro, Rita, Heller, Carolin, Hoegen, Tobias, Indakoetxea, Begoña, Jiskoot, Lize, Karnath, Hans-Otto, Keren, Ron, Langheinrich, Tobias, Leitão, Maria João, Lladó, Albert, Lombardi, Gemma, Loosli, Sandra, Maruta, Carolina, Mead, Simon, Meeter, Lieke, Miltenberger, Gabriel, van Minkelen, Rick, Mitchell, Sara, Moore, Katrina, Nacmias, Benedetta, Nicholas, Jennifer, Olives, Jaume, Ourselin, Sebastien, Padovani, Alessandro, Panman, Jessica, Papma, Janne M., Peakman, Georgia, Pievani, Michela, Pijnenburg, Yolande, Polito, Cristina, Premi, Enrico, Prioni, Sara, Prix, Catharina, Rademakers, Rosa, Redaelli, Veronica, Rittman, Tim, Rogaeva, Ekaterina, Rosa-Neto, Pedro, Rossi, Giacomina, Rosser, Martin, Santiago, Beatriz, Scarpini, Elio, Schönecker, Sonja, Semler, Elisa, Shafei, Rachelle, Shoesmith, Christen, Tábuas-Pereira, Miguel, Tainta, Mikel, Taipa, Ricardo, Tang-Wai, David, Thomas, David L., Thompson, Paul, Thonberg, Håkan, Timberlake, Carolyn, Tiraboschi, Pietro, Todd, Emily, Van Damme, Philip, Vandenbulcke, Mathieu, Veldsman, Michele, Verdelho, Ana, Villanua, Jorge, Warren, Jason, Wilke, Carlo, Woollacott, Ione, Wlasich, Elisabeth, Zetterberg, Henrik, Zulaica, Miren · 2021 · Molecular Neurodegeneration
Cited by 36

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Background: A detailed understanding of the pathological processes involved in genetic frontotemporal dementia is critical in order to provide the patients with an optimal future treatment. Protein levels in CSF have the potential to reflect different pathophysiological processes in the brain. We aimed to identify and evaluate panels of CSF proteins with potential to separate symptomatic individuals from individuals without clinical symptoms (unaffected), as well as presymptomatic individuals from mutation non-carriers. Methods: A multiplexed antibody-based suspension bead array was used to analyse levels of 111 proteins in CSF samples from 221 individuals from families with genetic frontotemporal dementia. The data was explored using LASSO and Random forest. Results: When comparing affected individuals with unaffected individuals, 14 proteins were identified as potentially important for the separation. Among these, four were identified as most important, namely neurofilament medium polypeptide (NEFM), neuronal pentraxin 2 (NPTX2), neurosecretory protein VGF (VGF) and aquaporin 4 (AQP4). The combined profile of these four proteins successfully separated the two groups, with higher levels of NEFM and AQP4 and lower levels of NPTX2 in affected compared to unaffected individuals. VGF contributed to the models, but the levels were not significantly lower in affected individuals. Next, when comparing presymptomatic GRN and C9orf72 mutation carriers in proximity to symptom onset with mutation non-carriers, six proteins were identified with a potential to contribute to a separation, including progranulin (GRN). Conclusion: In conclusion, we have identified several proteins with the combined potential to separate affected individuals from unaffected individuals, as well as proteins with potential to contribute to the separation between presymptomatic individuals and mutation non-carriers. Further studies are needed to continue the investigation of these proteins and their potential association to the pathophysiological mechanisms in genetic FTD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-021-00499-4

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 36

Metadata

Authors
Bergström, S., Öijerstedt, L., Remnestål, J., Olofsson, J., Ullgren, A., Seelaar, H., van Swieten, J. C., Synofzik, M., Sanchez-Valle, R., Moreno, F., Finger, E., Masellis, M., Tartaglia, C., Vandenberghe, R., Laforce, R., Galimberti, D., Borroni, B., Butler, C. R., Gerhard, A., Ducharme, S., Rohrer, J. D., Månberg, A., Graff, C., Nilsson, P., (GENFI), O. B. O. T. G. F. D. I., Jiskoot, L., Rowe, J. B., de Mendonça, A., Tagliavini, F., Santana, I., Le Ber, I., Levin, J., Danek, A., Otto, M., Frisoni, G., Ghidoni, R., Sorbi, S., Pasquier, F., Jelic, V., Andersson, C., Afonso, S., Almeida, M. R., Anderl-Straub, S., Antonell, A., Archetti, S., Arighi, A., Balasa, M., Barandiaran, M., Bargalló, N., Bartha, R., Bender, B., Benussi, A., Benussi, L., Bessi, V., Binetti, G., Black, S., Bocchetta, M., Borrego-Ecija, S., Bras, J., Bruffaerts, R., Cañada, M., Cantoni, V., Caroppo, P., Cash, D., Castelo-Branco, M., Convery, R., Cope, T., Di Fede, G., Díez, A., Duro, D., Fenoglio, C., Ferrari, C., Ferreira, C. B., Fox, N., Freedman, M., Fumagalli, G., Gabilondo, A., Gasparotti, R., Gauthier, S., Gazzina, S., Giaccone, G., Gorostidi, A., Greaves, C., Guerreiro, R., Heller, C., Hoegen, T., Indakoetxea, B., Jiskoot, L., Karnath, H.-O., Keren, R., Langheinrich, T., Leitão, M. J., Lladó, A., Lombardi, G., Loosli, S., Maruta, C., Mead, S., Meeter, L., Miltenberger, G., van Minkelen, R., Mitchell, S., Moore, K., Nacmias, B., Nicholas, J., Olives, J., Ourselin, S., Padovani, A., Panman, J., Papma, J. M., Peakman, G., Pievani, M., Pijnenburg, Y., Polito, C., Premi, E., Prioni, S., Prix, C., Rademakers, R., Redaelli, V., Rittman, T., Rogaeva, E., Rosa-Neto, P., Rossi, G., Rosser, M., Santiago, B., Scarpini, E., Schönecker, S., Semler, E., Shafei, R., Shoesmith, C., Tábuas-Pereira, M., Tainta, M., Taipa, R., Tang-Wai, D., Thomas, D. L., Thompson, P., Thonberg, H., Timberlake, C., Tiraboschi, P., Todd, E., Van Damme, P., Vandenbulcke, M., Veldsman, M., Verdelho, A., Villanua, J., Warren, J., Wilke, C., Woollacott, I., Wlasich, E., Zetterberg, H., & Zulaica, M.
Venue
Molecular Neurodegeneration
Published
2021-11-27
Volume
16
Issue
1
Pages
79-79
ISSN
1750-1326 (ISSN-L)
OpenAlex
W3215312374
Cited by
36
References
23
FWCI
3.49
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study. https://app.cochat.ai/papers/10.1186/s13024-021-00499-4
The paper
Bergström, S., Öijerstedt, L., Remnestål, J., Olofsson, J., Ullgren, A., Seelaar, H., van Swieten, J. C., Synofzik, M., Sanchez-Valle, R., Moreno, F., Finger, E., Masellis, M., Tartaglia, C., Vandenberghe, R., Laforce, R., Galimberti, D., Borroni, B., Butler, C. R., Gerhard, A., . . . Zulaica, M. (2021). A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-021-00499-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.